Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alfacell’s cancer drug fails endpoint
The preliminary results are based on 320 evaluable events that occurred in the clinical trial out of a total of 428 patients randomized. The trial was designed to
The preliminary results are based on 320 evaluable events that occurred in the clinical trial out of a total of 428 patients randomized. The trial was designed to
The FDA indicated that the basis of its decision involved the appropriate use and interpretation of non-inferiority trials, including Acuity. The company disagrees with the agency on these
In this study, Tel Aviv University scientists lesion the brains of lab rats by using the 6OHDA toxin, in order to mimic the motor dysfunction of Parkinsonian patients.
The Aptima HPV assay is an amplified nucleic acid test that detects 14 high-risk human papillomavirus (HPV) types that are associated with cervical cancer. More specifically, the assay
Under the terms of the proposed merger, OncoGenex’s stock and debenture holders will receive approximately 37 million shares of Sonus common stock and OncoGenex will become a wholly
Polymers specifically designed to degrade under physiological conditions are often referred to as ‘absorbable’, ‘biodegradable’ or ‘bioresorbable’ polymers. With this in-licensing event, the Polymer Technology Group (PTG) will
Pursuant to the terms of the option agreement, Pipex has the option to exclusively license pending application and corresponding US patent application as well as patents issued and
A total of 20 US and international sites will enroll 650 women with uterine fibroids who are diagnosed with unexplained infertility. Half the women will undergo treatment with
The merger agreement provided for the acquisition of Taro by Sun for $7.75 per share and allowed either party to terminate after December 31, 2007. While Sun offered
Two marketing partners are expected to launch clopidogrel (original product: Plavix/Iscover by Bristol-Myers Squibb/Sanofi-Aventis) in Germany. Applications for approval in additional European countries are in preparation. Luzi von